Back to Authors

Rollins, Barret J.

Mayo Clinic

Brigham and Women's Hospital

Citations 1

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Emile, Jean‐François , Abla, Oussama , Fraitag, Sylvie , Horne, AnnaCarin , Haroche, Julien , Requena‐Caballero, Luis, Jordan, Michael B. , Allen, Carl E. , Charlotte, Frédéric , Egeler, R. Maarten , Herrera, Juana Gil, Henter, Jan‐Inge , Jankú, Filip , Mérad, Miriam , Rollins, Barret J., Tazi, Abdellatif , Vassallo, Robert , Weiss, Lawrence M. , Astigarraga, Itziar , Donadieu, Jean , Abdel‐Wahab, Omar , Diamond, Eli L. , Fischer, Alain , Picarsic, Jennifer , Rodríguez‐Galindo, Carlos , Vassallo, Robert , Emile, Jean-François , Allen, Carl E

Blood | March 10, 2016 | Volume: 127 | Issue: 22 | Pages: 2672-2681

10.1182/blood-2016-01-690636 Get It

Abstract The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.